Novo Nordisk MS-FAC2 is a facility for the manufacture of insulin pens. The factory is part of the major master plan for the area between Favrholm and Trollesminde, which Vilhelm Lauritzen Architects devised in collaboration with the landscape architect, Jeppe Aagaard Andersen.
The facility has a disciplined, yet textural expression, in which an overall grid unifies a structure of steel frames, dark brick-veneer fillings, and glass sections.
There is a clear hierarchy in the way the façade materials differentiate the factory’s different units while supporting way-finding and clarity. The production building and the warehouse have a monolithic appearance, clad with tiles, while the administration building is designed with dark, homogeneous glass cladding.
The building is designed so that the individual functions – factory, warehouse, goods reception, and dispatch – stand out clearly and can be expanded independently of each other. The large depths of the rooms, which are necessary for this specialised production, are broken down into carefully balanced built structures, so the overall complex fits in with the landscape and the structural industrial context, in which it is located.
The building is a natural part of the Novo Nordisk campus, which is being realised on an on-going basis in accordance with the master plan and developments in Novo Nordisk.
The insulin pen factory was constructed as a partnering project with the participation of: the client, Novo Nordisk A/S Hillerød; the engineering firm, Novo Nordisk Engineering A/S; Vilhelm Lauritzen Architects; and the construction company, NCC Danmark A/S. The project was successfully implemented in accordance with the ‘Partnering in Practice’ guidelines.